ISPOR 21ST ANNUAL INTERNATIONAL MEETING WORKSHOP EXAMINES METHODOLOGIES FOR EVALUATING GEOSPATIAL ACCESS

Published May 25, 2016
Washington, DC—May 25, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Workshop 23—Methodologies for Evaluating Geospatial Access in Medication Use Studies—was held this afternoon in Washington, DC, USA. The discussion leaders for the session included:
  • Rajesh Balkrishnan, PhD, Professor, Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA
  • Xi Tan, PhD, PharmD, Assistant Professor, Department of Pharmaceutical Systems and Policy, West Virginia University, School of Pharmacy, Morgantown, WV, USA
  • Joseph Donohoe, PhD, Informatics and Special Projects Lead, Mountain-Pacific Quality Health, Helena, Helena, MT, USA
Large database studies that analyze health outcomes for medications often find significant variation in utilization due to differential geographical access. Discussion leaders reviewed newer measures and techniques of geospatial access to medications, including two-step floating catchment area (2SFCA), geographic hot spot analyses, and geographic weighted regression in evaluating the access and utilization of adjuvant endocrine therapy in breast cancer survivors residing in Appalachia, a poor and underserved region in the US with significant geospatial access issues. Presentations and slide decks from the ISPOR 21st Annual International meeting can be found here. Interested parties can follow news and developments from the meeting on social media using the hashtag #ISPORDC.

###

Related Stories

Global Expert Panel Releases Good Practices Guidance for Developing or Updating Health Technology Assessment Guidelines

Jan 14, 2025

ISPOR announced today the publication of a tripartite task force report outlining good practices for developing or updating health technology assessment (HTA) guidelines.

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.

ISPOR Launches “HEOR Explained” Microsite

Dec 10, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that it has launched a new microsite—HEOR Explained—designed to help people better understand how health economics and outcomes research (HEOR) can improve healthcare decisions.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×